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Carbon disulfide toxicity is well cbrcterize&d The principal target organ is the nervous system,
althoughcardiovascular, reproductive, ophalmologic, and othereffects are also recognized. The
neurotoxicity manifests in threeways: encephalopathy perphel and cranial nerve dysfunction,
andmovementabnormaities.This reportdescribes acaseofolivopontocerebellar atrophy, aform
ofmultiplesystematrophy, developinginanadultafterover30years ofoccupationalewposure to
carbon disulfide. Thepatientpresentedwith the insidious onset ofbalanceproblems, impotence,
and irritability, without tremor, cogwheel rgidity, bradykinesia, orchange in facial expression.
Over the ne few years severe ataxia developed, and the dinical diagnosis was confirmed with
computed tomogaphy and magetc reonance imaging scans. The patientexperienced multiple
medical complcions anddiedapproximately9 yearsafterdiagnosis. This case isconsistentwith
alarge bodyofclinical andepeental literature, much ofit 50 years old, showing thatcarbon
disulfide can cause movement disorders. It also serves as a reminder that movement disorders,
ranging from parknsnism to dystonia, are assciated with a variety oftoxiceposures such as
manganese, carbon monoxide, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, and medications.
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Carbondisuffideisaclear, colorlessvolatilesol-
vent used in manufacturing viscose rayon, rub-
ber, cellophane, carbon tetrachloride, and pes-
ticides; as a fumigant; and in other applica-
tions. A wide range oftoxic effects, induding
cardiovascular, ocular, andreproductive effects,
has been well recognized for over a century
(1-4). The nervous system, however, is the
principal targetorganofcarbondisulfide.
There are three principal manifestations
ofcarbon disulfide neurotoxicity: acute and
chronic encephalopathy, peripheral and cra-
nial neuropathy, and movement disorders.
The majorfocus ofrecent literature has been
on encephalopathy following low-level
exposures. This syndrome includes subjec-
tive symptoms such as headache and vertigo
and changes in affect and cognition (5-7).
Movement disorders have received much
less attention. This paper presents a case of
multiple system atrophy developing after
long-term exposure to carbon disulfide.
Case Presentation
The patient first presented at approximately
60years ofagewithslowlyprogressive balance
problems, impotence, irritability, and emo-
tional lability. His balance and coordination
worsened until, by age 62, he had difficulty
with walking, manual dexterity, and speech.
Healso noted severe nightmares. Therewere
no tremors, no changes in facial expression,
no cogwheel rigidity, no bradykinesia, and
no impairment ofhearing or vision. A mag-
netic resonance image (MRI) at age 63 gave
equivocal results (variously interpreted as
normal or mild cerebellar atrophy), but a
repeat MRI ayearlatershoweddefinite cere-
bellar and brainstem atrophy. Thyroid func-
tion, urinary lead and mercury levels, serum
vitamin B12 levels, and electroencephalogra-
phywere normal.
At age 64, the patient was evaluated by a
neurologist. Bloodpressurewas 160/80 with-
out orthostatic changes; speech was slightly
slurred; cognition and affect were generally
intact; and cranial nerve function was nor-
mal. Motor examination revealed normal
strength without involuntary movements,
but with rippling movements oflarge mus-
des in the chest and lower extremities. There
were impairments offinger-to-nose, heel-
knee-shin, and rapid alternating movements.
The patient was unable to tandem walk and
was unstable when standing with his feet
dose together, evenwith his eyes open. Deep
tendon reflexes were normal, and no patho-
logical reflexes were present. A computed
tomography (CT) scan showed atrophyofthe
cerebellar and pontine regions. He was diag-
nosed with olivopontocerebellar atrophy of
thesporadictype.
In the next few years, the patient experi-
enced progressive deterioration in function.
Dysphagia, dysarthria, and ataxia increased.
Byage 67hehad become unable towalkand
had little functional independence. He also
suffered multiple medical complications
including rectal bleeding, neurogenic bladder
with chronic urinary infections requiring
intermittent catheterization, a fungal infec-
tion ofthe mouth, peptic ulcerdisease, bron-
chitis with dysphagia, gynecomastia (proba-
blysecondaryto ranitidine use), andhiccups.
A repeat MRI ofthe brain at age 68 (see Fig.
1) showed advanced cerebellar atrophy and
prominent atrophy in the posterior tracts
and nuclei of the pons. The patient died at
theage of69. No autopsywas performed.
Previous medical historywas remarkable
only for benign positional vertigo, hiccups,
some orthostatic hypotension, peptic ulcer
disease, and prostatic hypertrophy. The
patient had completed high school. He was
alifelong nondrinker and nonsmoker.
The patient had been employed from
age 25 to age 59 in a plant that produced
viscose rayon. During most ofthis time, he
worked in the spinning room. Although
measured air levels ofcarbon disulfide from
his plant were not available, the spinning
room has been reported to pose some ofthe
highest carbon disulfide levels in rayon man-
ufacturing (8), ranging from 10 to 20 ppm
(31-62 mg/m3) and sometimes reaching 30
ppm (93 mg/m3) orhigher (9-13).
Discussion
Olivopontocerebellar atrophy belongs to the
multiple systematrophyfamilyofneurologic
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disorders (14,15). This complex is character-
ized by autonomic dysfunction, parkinson-
ism, and ataxia, which may occur in any
combination. Common findings include
bradykinesia with rigidity, tremor, or both
(poorly responsive to levodopa therapy);
cerebellar or corticospinal signs; orthostatic
hypotension; impotence; and urinary incon-
tinence or retention. A predominance of
parkinsonism is termed striatonigral degen-
eration, while apredominance ofautonomic
dysfunction is termed Shy-Drager syn-
drome. When cerebellar dysfunction pre-
dominates, as in the present case, the term
olivopontocerebellar atrophy is used.
In these disorders several parts of the
brain, many of them involved in motor
activity, are affected by neuronal loss and
gliosis, induding the neostriatum, the sub-
stantia nigra, the globus pallidus, the cere-
bellum, the inferior olives, the basis pontine
nudei, the intermediolateral horn cells, the
anterior horn cells, and the corticospinal
tracts. Oligodendroglial tangle-like inclu-
sions, called glial cytoplasmic indusions or
oligodendroglial microtubular tangles, are a
common pathologic finding (15). While
olivopontocerebellar atrophy is distin-
guished from the other types of multiple
system atrophy by the relative prominence
ofataxia, there can be considerable parkin-
sonism as well, especially in the sporadic (as
opposed to the familial) form. The most
common parts ofthe brain affected are the
olives, pons, and cerebellum, as well as the
striatum and substantia nigra (16).
Clinical accounts ofmovement disorders
among carbon disulfide workers, dating
from at least as far back as the 1930s, have
described tremor, involuntary movements,
and parkinsonism (3,17-23). More recently,
Peters et al. (24) described a syndrome of
atypical parkinsonism, cerebellar signs, hear-
ing loss, and sensory changes in 21 workers
with carbon disulfide exposure. Ataxia was
present in 8 ofthe 21 workers. In a study of
16 workers with long-term carbon disulfide
exposure, Aaserud et al. (6) found that the
most common clinical abnormality (appear-
ing in eight individuals) was coordination
deficit. Two of the patients in this study
had visible cerebellar atrophy on CT scans.
Huang et al. (25) reported a detailed neu-
rologic investigation of 10 patients with
"polyneuropathy and various neuropsychi-
atric symptoms" following carbon disul-
fide exposure. In four cases, brain MRI
revealed lesions of the basal ganglia and
corona radiata.
Pathological findings in humans fol-
lowing carbon disulfide exposure have only
rarely been reported. They include neu-
ronal degeneration diffusely over the cere-
bral cortex, globus pallidus, and putamen,
and a decrease in Purkinje cells in the cere-
bellar cortex (26,24.
Animal studies demonstrate clinical and
pathological changes that correspond to
these human observations. In dog and cat
studies, carbon disulfide exposure led to a
syndrome ofataxia, tremor, myodonicjerks,
spasticity, muscular atrophy, and aggressive
behavior (26,28); pathological damage was
seen in the frontal cortex, caudate, putamen,
and Purkinje cell layer. Richter (29) exposed
rhesus monkeys to carbon disulfide; they
developed an extrapyramidal syndrome with
flexor dystonia, slowness of movement,
rigidity, and tremor. The globus pallidus
and substantia nigra were the most severely
affected parts ofthe brain, while the cortex
was relatively spared. In more recent rat
studies, dose-related gait abnormalities were
the first manifestation ofexposure, although
this mayhave reflected peripheral nerve tox-
icity rather than extrapyramidal effects (30).
Pathological findings were not reported.
Other work on rats has helped clarify the
mechanisms ofcarbon disulfide axonal toxi-
city (31), but it is not dear ifthese findings
can be applied to the cerebellum or
extrapyramidal pathways.
Carbon disulfide exposure is primarily a
workplace concern, and ambient environ-
mental exposures are ordinarily low (4).
However, ambient environmental expo-
sures may occur. In 1996, 137 facilities in
the United States reported carbon disulfide
emissions to the EPA Toxics Release
Inventory. At the viscose rayon plant that
employed this patient, combined fugitive
and stack emissions of carbon disulfide
totaled 33.4 million pounds in 1995 and
27.7 million pounds in 1996-nearly 50
tons each day (32). In addition to these
ongoing emissions, acute releases ofcarbon
disulfide during transport remain a possi-
bility. There is at least one report of cere-
bral damage following a single exposure to
carbon disulfide (33). Therefore, environ-
mental exposure to carbon disulfide,
although rare, remains a concern.
This case also serves as a reminder that
movement disorders may result from other
environmental exposures. Manganese causes
a parkinsonian syndrome (34,35). This is
especially worrisome in view of two recent
disclosures: the very high prevalence of
parkinsonian symptoms among the elderly
(36) and the possible impending increase in
Fgr1.Mgeireoacimgshwnoivpnoeeelrarpyiapainwh ha di
Figure 1. Magnetic resonance image showing olivopontocerebellar atrophy in a patientwho had been occupationally exposed to carbon disulfide for over30years.
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environmental manganese exposure due to
the use of methylcyclopentadienyl man-
ganese tricarbonyl in gasoline (35). Acute
high-level exposures to carbon monoxide
and perhaps methanol can cause residual
parkinsonism (34), and lightning and elec-
trical injuries have been reported to cause
dystonia, choreoathetosis, myoclonus, and
other movement disorders (327). Avariety of
medications can cause dyskinesias (38), and
the major experimental model of parkin-
sonism, 1-methyl-4-phenyl-1,2,3,6-tetrahy-
dropyridine (MPTP) was discovered as a
contaminant of drugs ofabuse (39). Thus,
environmental and occupational exposures
can cause avarietyofmovement disorders.
Conclusion
This patient presented with olivoponto-
cerebellar atrophy following over 30 years
of high-level exposure to carbon disulfide.
While this association has not previously
been reported, it is clinically and pathologi-
cally consistent with a range of movement
disorders seen in the setting ofoccupation-
al carbon disulfide exposure.
Industrial exposures to carbon disulfide
have decreased in industrialized nations in
recent years as a result ofheightened aware-
ness of the solvent's toxicity, enclosure of
some production processes, improvements
in ventilation, and replacement of carbon
disulfide by other agents. However, carbon
disulfide continues to be an important
industrial chemical. High occupational
exposures still occur, especially in develop-
ing nations, and environmental exposures
may occur as well. Clinicians should be
alert to the possibility of movement disor-
ders among patients with carbon disulfide
exposure, in addition to the better recog-
nized toxic manifestations ofthis chemical.
Clinicians should also be aware of the
potential ofother environmental exposures
to cause movement disorders.
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